Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series.
Gori N, Ippoliti E, Ferrucci SM, Balato A, Ortoncelli M, Maurelli M, Galluzzo M, Munera Campos M, Seremet T, Di Nardo L, Antonelli F, Coscarella G, Conrad C, Carrascosa JM, Bianchi L, Argenziano G, Ribero S, Girolomoni G, Marzano AV, Chiricozzi A, Peris K; MEDaCoTRA Study Group. Gori N, et al. Among authors: di nardo l. J Eur Acad Dermatol Venereol. 2024 Feb 29. doi: 10.1111/jdv.19929. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38421043 No abstract available.
Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study.
Chiricozzi A, Balato A, Fabbrocini G, Di Nardo L, Babino G, Rossi M, Esposito M, Bertoldi AM, Girolomoni G, Gambardella A, Antonelli F, Patruno C, Fargnoli MC, Argenziano G, Peris K. Chiricozzi A, et al. Among authors: di nardo l. J Am Acad Dermatol. 2023 Dec;89(6):1251-1253. doi: 10.1016/j.jaad.2023.05.001. Epub 2023 May 9. J Am Acad Dermatol. 2023. PMID: 37169293 No abstract available.
The psychological burden during COVID-19 pandemic in a cohort of patients affected by moderate-to-severe atopic dermatitis treated with dupilumab.
Quattrini L, Chiricozzi A, Gori N, DI Nardo L, D'Urso DF, Malvaso D, Cornacchia L, Catapano S, Peris K. Quattrini L, et al. Among authors: di nardo l. Ital J Dermatol Venerol. 2023 Aug;158(4):365-367. doi: 10.23736/S2784-8671.23.07475-3. Epub 2023 Jul 11. Ital J Dermatol Venerol. 2023. PMID: 37432395 No abstract available.
Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort Study.
Antonelli F, Ippoliti E, Rosi E, Moltrasio C, Malvaso D, Botti E, Abeni D, Dini V, Cannizzaro MV, Bruni M, Di Nardo L, Fargnoli MC, Romanelli M, Fania L, Bianchi L, Marzano AV, Prignano F, Peris K, Chiricozzi A. Antonelli F, et al. Among authors: di nardo l. J Clin Med. 2023 Dec 18;12(24):7754. doi: 10.3390/jcm12247754. J Clin Med. 2023. PMID: 38137823 Free PMC article.
Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilled.
Coscarella G, Falco GM, Palmisano G, Ippoliti E, De Luca E, Gori N, Di Nardo L, Caldarola G, De Simone C, Chiricozzi A, Peris K. Coscarella G, et al. Among authors: di nardo l. Front Med (Lausanne). 2024 Jan 11;10:1295973. doi: 10.3389/fmed.2023.1295973. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38274451 Free PMC article.
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study.
Gori N, Sernicola A, Tolino E, Mariano M, Galluzzo M, Moretta G, Coppola R, D'Alessio A, Sansone M, Maffei V, Paolino C, Ferrao C, Cascia L, Addio P, Di Nardo L, Chiricozzi A, Del Duca E, Cristaudo A, Bianchi L, Pallotta S, Panasiti V, Pellacani G, Potenza C, Peris K. Gori N, et al. Among authors: di nardo l. J Dermatolog Treat. 2023 Dec;34(1):2230685. doi: 10.1080/09546634.2023.2230685. J Dermatolog Treat. 2023. PMID: 37400981 Free article.
87 results